Wilate (human factor VIII/von Willebrand factor) / Octapharma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wilate (human factor VIII/von Willebrand factor) / Octapharma
NCT04953884 / 2020-004344-28: Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease VWD) Patients <6 Years of Age

Active, not recruiting
3
12
Europe, US, RoW
wilate
Octapharma
Von Willebrand Disease
12/24
12/24
EMPOWER, NCT06205095: A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients With VWD

Not yet recruiting
3
20
NA
Lyophilized concentrate of human coagulation von Willebrand Factor and factor VIII, Wilate, Placebo
Unity Health Toronto
Von Willebrand Diseases
09/26
09/26

Download Options